DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Haller D, Tabernero J, Maroun J. et al.
5LBA First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study).
Eur J Cancer Suppl 2009; 7: 4-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.